miR-139 Functions as an Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β

Technology in Cancer Research and Treatment - United States
doi 10.1177/1533034616630866
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

circKIF4A Promotes Tumorogenesis of Glioma by Targeting miR-139-3p to Activate Wnt5a Signaling

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2020English

Targeting Stearoyl-CoA Desaturase1 to Repress Endometrial Cancer Progression

Oncotarget
Oncology
2018English

RETRACTION NOTICE for MiR-592 Functions as a Tumor Suppressor in Glioma by Targeting IGFBP2

Tumor Biology
MedicineCancer Research
2018English

CircNFIX Promotes Progression of Glioma Through Regulating miR-378e/RPN2 Axis

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

miR-185 Silencing Promotes the Progression of Atherosclerosis via Targeting Stromal Interaction Molecule 1

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2019English

miR-15a-3p and miR-16-1-3p Negatively Regulate Twist1 to Repress Gastric Cancer Cell Invasion and Metastasis

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2017English

Estrogen Utilization of IGF-1-R and EGF-R to Signal in Breast Cancer Cells

Journal of Steroid Biochemistry and Molecular Biology
Molecular MedicineCell BiologyMolecular BiologyBiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2010English

MiR-30a Attenuates Immunosuppressive Functions of IL-1β-elicited Mesenchymal Stem Cells via Targeting TAB3

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2015English

HOXD-AS1 Functions as an Oncogenic ceRNA to Promote NSCLC Cell Progression by Sequestering miR-147a

OncoTargets and Therapy
OncologyPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy